Challenges in clinical trial design in inflammatory arthritis

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

The prognosis for patients with rheumatoid arthritis has improved dramatically, thanks in large part to many new therapies and therapeutic approaches. Paradoxically, this has created problems for rheumatologists since clinically useful information from appropriate clinical trials has not kept pace with all the new therapeutic options. Essentially, rheumatologists now have many more therapeutic options than they know what to do with. This article discusses why we are in this situation and suggests opportunities to move forward.

Original languageEnglish (US)
Pages (from-to)457-461
Number of pages5
JournalBest Practice and Research: Clinical Rheumatology
Volume24
Issue number4
DOIs
StatePublished - Aug 1 2010

Fingerprint

Arthritis
Clinical Trials
Therapeutics
Rheumatoid Arthritis
Rheumatologists

Keywords

  • clinical trials
  • comparative effectiveness research
  • ethics
  • rheumatoid arthritis

ASJC Scopus subject areas

  • Rheumatology

Cite this

Challenges in clinical trial design in inflammatory arthritis. / O'Dell, James Robert.

In: Best Practice and Research: Clinical Rheumatology, Vol. 24, No. 4, 01.08.2010, p. 457-461.

Research output: Contribution to journalReview article

@article{d613a875d15443f29b29635f62dde237,
title = "Challenges in clinical trial design in inflammatory arthritis",
abstract = "The prognosis for patients with rheumatoid arthritis has improved dramatically, thanks in large part to many new therapies and therapeutic approaches. Paradoxically, this has created problems for rheumatologists since clinically useful information from appropriate clinical trials has not kept pace with all the new therapeutic options. Essentially, rheumatologists now have many more therapeutic options than they know what to do with. This article discusses why we are in this situation and suggests opportunities to move forward.",
keywords = "clinical trials, comparative effectiveness research, ethics, rheumatoid arthritis",
author = "O'Dell, {James Robert}",
year = "2010",
month = "8",
day = "1",
doi = "10.1016/j.berh.2009.11.008",
language = "English (US)",
volume = "24",
pages = "457--461",
journal = "Best Practice and Research in Clinical Rheumatology",
issn = "1521-6942",
publisher = "Bailliere Tindall Ltd",
number = "4",

}

TY - JOUR

T1 - Challenges in clinical trial design in inflammatory arthritis

AU - O'Dell, James Robert

PY - 2010/8/1

Y1 - 2010/8/1

N2 - The prognosis for patients with rheumatoid arthritis has improved dramatically, thanks in large part to many new therapies and therapeutic approaches. Paradoxically, this has created problems for rheumatologists since clinically useful information from appropriate clinical trials has not kept pace with all the new therapeutic options. Essentially, rheumatologists now have many more therapeutic options than they know what to do with. This article discusses why we are in this situation and suggests opportunities to move forward.

AB - The prognosis for patients with rheumatoid arthritis has improved dramatically, thanks in large part to many new therapies and therapeutic approaches. Paradoxically, this has created problems for rheumatologists since clinically useful information from appropriate clinical trials has not kept pace with all the new therapeutic options. Essentially, rheumatologists now have many more therapeutic options than they know what to do with. This article discusses why we are in this situation and suggests opportunities to move forward.

KW - clinical trials

KW - comparative effectiveness research

KW - ethics

KW - rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=77956168403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956168403&partnerID=8YFLogxK

U2 - 10.1016/j.berh.2009.11.008

DO - 10.1016/j.berh.2009.11.008

M3 - Review article

C2 - 20732644

AN - SCOPUS:77956168403

VL - 24

SP - 457

EP - 461

JO - Best Practice and Research in Clinical Rheumatology

JF - Best Practice and Research in Clinical Rheumatology

SN - 1521-6942

IS - 4

ER -